Karnataka, India

Thaslim Basha

This inventor holds 1 USPTO granted patent. Top assignee: Micro Labs Ltd.. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thaslim Basha: Innovator in Pharmaceutical Chemistry

Introduction

Thaslim Basha is a notable inventor based in Karnataka, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of novel compounds. His work is characterized by a focus on innovative processes that enhance the efficacy of pharmaceutical products.

Latest Patents

Thaslim Basha holds a patent for the "Process for the preparation of (S)-Netarsudil, its salts and polymorphs." This invention relates to a method for synthesizing (S)-Netarsudil and its pharmaceutically acceptable salts using novel intermediates. The patent also encompasses the development of novel salts, intermediates, and polymorphic forms of (S)-Netarsudil salts, along with the processes for their preparation. He has 1 patent to his name.

Career Highlights

Thaslim Basha is currently employed at Micro Labs Ltd., where he continues to advance his research and development efforts. His work at the company has positioned him as a key player in the pharmaceutical industry, contributing to the development of innovative therapeutic solutions.

Collaborations

Thaslim collaborates with talented individuals such as Golla Maghava and Peyalla Divya, who contribute to his projects and research initiatives. Their teamwork fosters a creative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Thaslim Basha's contributions to pharmaceutical chemistry exemplify the spirit of innovation in the industry. His patent on (S)-Netarsudil showcases his commitment to advancing medical science through inventive processes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…